Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Florida divided over genetically modified mosquitoes
Voters in Florida are divided on whether or not to use genetically modified mosquitoes in the fight against Zika and other viruses.
Referendum reveals concerns over planned release

Voters in Florida are divided on whether or not to use genetically modified mosquitoes in the fight against Zika and other viruses, according to the Centre for Infectious Disease Research and Policy.

The Centre say that, in a non-binding referendum, 58 per cent of voters in Monroe County voted in favour of using the mosquitoes. Meanwhile in Key Haven - a neighbourhood where the insects would be released next spring - 65 per cent of voters opposed the idea.

In spite of the need for mosquito control, locals worry that genetically modified mosquitoes may pose an unpredicted environmental threat. It is thought that early reports, which erroneously linked microcephaly to genetically modified mosquitoes, may also have a part to play in the doubt.

The genetically modified mosquitoes are manufactured by British company Oxitec, who plan to assess their effectiveness for fighting Zika.  According to BBC News, Oxitec want to release male insects across a 17-hectare region of Key Haven, a small suburb located on an island on Florida’s southern tip.

The US Food & Drug administration approved Oxitec’s mosquitoes for use in August, saying that, following months of comments from the public, the mosquitos fell under the category of Finding of No Significant Impact (FONSI).

The results of the Florida poll will now be put to board members on 19 November, who will make the final decision on whether the mosquitoes will be used next spring.

Speaking to BBC News, Dr Derric Nimmo, who has been leading Oxitec’s proposed trial in Key Haven, said: We've had six years of releases, involving millions of male mosquitoes, and there have been no reports of any adverse effects."

"It's important we're as transparent as possible... we've been trying to give people the facts and information so they can make an informed choice."

Become a member or log in to add this story to your CPD history

FIVP publishes CMA Compliance Checklist

News Story 1
 FIVP has published a CMA Compliance Checklist to support independent practices with the Market Investigation Order.

The document includes deadlines for small and large businesses, with tick boxes for each of the tasks. The organisation also invites practices to contact them for support with requirements.

Rita Dingwall, FIVP chair, said: FIVP appreciates that navigating the new CMA requirements can feel daunting. We hope this checklist will make things a little easier, helping independent practices work through what is required with confidence. 

Click here for more...
News Shorts
APHA launches free virtual work experience programme

The Animal and Plant Health Agency (APHA), in collaboration with Springpod, has launched a free virtual work experience programme, giving young people across the UK the chance to explore careers dedicated to protecting animal and plant health.

The on-demand programme offers a unique insight into career opportunities within APHA, showcasing how students can contribute to tackling some of the UK's most critical biosecurity and environmental challenges.

Designed for students aged 13 and over, the course includes more than 10 hours of engaging content featuring real-life industry insights, scenario-based challenges, and practical guidance on applying for jobs. To register for the course, visit the APHA website.